These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7821306)

  • 1. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Eur Heart J; 1994 Oct; 15(10):1300-31. PubMed ID: 7821306
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Atherosclerosis; 1994 Oct; 110(2):121-61. PubMed ID: 7848365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
    Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
    de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
    Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of coronary disease in clinical practice. Guidelines of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyorala K; De Backer G; Graham I; Poole-wilson P; Wood D
    G Ital Cardiol; 1996 Feb; 26(2):127-68. PubMed ID: 8666173
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risk factor treatment and control in relation to coronary disease risk in the Spanish population of the DARIOS Study].
    Baena-Díez JM; Félix FJ; Grau M; Cabrera de León A; Sanz H; Leal M; Elosua R; Rodríguez-Pérez Mdel C; Guembe MJ; Torán P; Vega-Alonso T; Ortiz H; Pérez-Castán JF; Frontera-Juan G; Lapetra J; Tormo MJ; Segura A; Fernández-Bergés D; Marrugat J
    Rev Esp Cardiol; 2011 Sep; 64(9):766-73. PubMed ID: 21764497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D; Force T
    Cardiologia; 1996 Feb; 41(2):149-82. PubMed ID: 8674094
    [No Abstract]   [Full Text] [Related]  

  • 8. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
    Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, The European Atherosclerosis Society and the European Hypertension Society. A short overview for general practitioners].
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Lijec Vjesn; 1996 Oct; 118(10):220-6. PubMed ID: 9132519
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of coronary disease in clinical practice. Recommendations of the Task-Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
    Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):379-88. PubMed ID: 8561444
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.
    Eur Heart J; 1998 Oct; 19(10):1434-503. PubMed ID: 9820987
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    J Hypertens; 1998 Oct; 16(10):1407-14. PubMed ID: 9814610
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of coronary heart diseases in clinical practice. Comment on the recommendations of the Second Joint Task Force of European Societies for Prevention of Coronary Disease].
    Klein W; Maurer G; Patsch JR; Sandhofer F; Silberbauer K
    Wien Med Wochenschr; 1999; 149(5-6):111-8. PubMed ID: 10408001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of HeartQoL in patients with coronary heart disease: Association with risk factors and European reference values. The EUROASPIRE IV study of the European Society of Cardiology.
    De Smedt D; Clays E; Höfer S; Oldridge N; Kotseva K; Maggioni AP; Pogosova N; Dolzhenko M; De Bacquer D
    Eur J Prev Cardiol; 2016 Jul; 23(11):1174-86. PubMed ID: 26862122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].
    Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M
    Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
    Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D;
    Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations for an extensive risk decrease for patients with coronary disease, vascular diseases and diabetes. Issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research, reviewed on behalf of the Clinical Cardiology Commission by the Prevention Project Group].
    Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G;
    Z Kardiol; 2001 Feb; 90(2):148-9. PubMed ID: 11263006
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines--a missed opportunity.
    Wood D
    Atherosclerosis; 1999 May; 143 Suppl 1():S7-12. PubMed ID: 10382832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    Atherosclerosis; 1998 Oct; 140(2):199-270. PubMed ID: 9862269
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular rehabilitation in patients with diabetes.
    Mourot L; Boussuges A; Maunier S; Chopra S; Rivière F; Debussche X; Blanc P
    J Cardiopulm Rehabil Prev; 2010; 30(3):157-64. PubMed ID: 20040882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.